Completed PHASE4 INTERVENTIONAL 1-arm NCT03163342

Immune Response Following Seasonal Influenza Vaccination

Extent and Durability of Immune Response Following Seasonal Influenza Vaccination in Healthy Volunteers

Sponsor: Altimmune, Inc.

Conditions Influenza

Interventions Licensed seasonal influenza vaccine

Updated 9 times since 2017 Last updated: Apr 4, 2019 Started: May 8, 2017 Primary completion: Nov 21, 2017 Completion: Jun 15, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Influenza, this trial is completed. The trial is conducted by Altimmune, Inc. and has accumulated 9 data snapshots since 2017. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2023 — Jul 2024 [monthly]

Completed PHASE4
Dec 2022 — Jan 2023 [monthly]

Completed PHASE4
Jan 2021 — Dec 2022 [monthly]

Completed PHASE4

▶ Show 4 earlier versions

May 2019 — Jan 2021 [monthly]

Completed PHASE4

Status: Active Not Recruiting → Completed
Jun 2018 — May 2019 [monthly]

Active Not Recruiting PHASE4
Jan 2018 — Jun 2018 [monthly]

Active Not Recruiting PHASE4
Jun 2017 — Jan 2018 [monthly]

Active Not Recruiting PHASE4

First recorded

May 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Altimmune, Inc.
Optimal Health Research

Data source: Altimmune, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rockville, United States